| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |